17.01.2017 10:10

“GO DIGITAL” - Be an Innovator challenge call for application

Bearing point invites students and graduates from five European countries including Switzerland to apply for the Be an Innovator challenge 2017. Selected startups will present before the jury in Berlin. Three winners will be awarded accordingly. Application is possible until 31st March 2017.

17.01.2017 09:15

Malin acquires Swiss biotech company Cilatus BioPharma AG

Malin Corporation plc, an Irish-based and globally operating life sciences company, announced that it has acquired an 80 percent shareholding of Cilatus BioPharma AG. Cilatus specialises in strategic and operational consulting services for small, medium and large biopharma Companies.


16.01.2017 15:15

The next venture leaders’ plane to land in Boston and China

Venturelab is organising the next startup development programs for hightech startups to China and life sciences to Boston. 10 selected startups from each category will have the opportunity to explore the foreign market while expanding their business and personal networks. Registration is open.

16.01.2017 11:30

“Nobody cares about your technology”

The Lausanne based startup Teleport offers a SaaS platform that enables users to create interactive videos. Two months ago, the startup was selected to participate in the American accelerator “500 startups”. Gavrilo Bozovic, CEO of Teleport, shares his experience and achievements in this interview.

16.01.2017 09:15

A successful year for Swiss blockchain startup Decent

DECENT is an Open-Source decentralized content distribution platform that utilizes Blockchain to ensure trust and security for content creators and enterprises. After the raising over $4.2 million worth of Bitcoins from their Initial Coin Offering, the startup expanded to China and closed additional partnerships.

16.01.2017 08:48

Xigen’s Brimapitide Delivers Positive Phase II Results in Inflammatory Eye Disease

Xigen, a SwissCompany developing therapeutic peptides for the treatment of inflammatory diseases, announced the online publication of successful Phase II results for its lead compound Brimapitide (XG-102) in the American Journal of Ophthalmology.


13.01.2017 12:40

Anokion Announces Exclusive Strategic Collaboration with Celgene

Under the terms of the collaboration agreement, Anokion received a $45 million upfront payment and is eligible to receive a future payment of an additional $10 million based on certain preclinical development achievements. As part of the strategic collaboration agreement, Celgene obtained an equity interest in Anokion and the exclusive right to acquire Anokion at pre-specified option exercise points.

Show All


24th - 25th Jan 2017 08:00-18:00

WorldWebForum 2017 Stage one, Elias-Canetti-Strasse 146, 8050 Zurich

Show All


25.01.2017 17:00

Technologie- und Innovationsförderung: Welche Finanzierungsquellen gibt es? Auditorium Hochschule Luzern - Wirtschaft, Luzern

Top viewed

Show All




Apply now for the Swiss Economic Award 2017

Deadline for Swiss Economic Award is 31 January. As well as prize money of CHF 25,000, each winner receives a comprehensive and customised package of support.